Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Foshou Weian (also known as Foshou Weian Granules) is a Traditional Chinese Medicine (TCM) candidate developed by the Qingdao Haichuan Innovation Bio-Natural Medicine Research Center in collaboration with Shandong University of Traditional Chinese Medicine. It is specifically formulated for the treatment of chronic non-atrophic gastritis, particularly in patients presenting with the TCM syndrome of liver-stomach disharmony (肝胃不和). The drug is derived from natural botanical sources, with *Citrus medica* var. *sarcodactylis* (Finger Citron or Foshou) serving as a primary active component. Its therapeutic mechanism is based on TCM principles of regulating Qi, soothing the liver, and harmonizing the stomach to alleviate symptoms such as epigastric pain, bloating, and acid reflux. Pharmacologically, it is intended to provide gastric mucosal protection and exert anti-inflammatory effects to promote the repair of the stomach lining.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Foshou Weian.